Literature DB >> 21270327

Bone mineral density and testicular failure: evidence for a role of vitamin D 25-hydroxylase in human testis.

Carlo Foresta1, Giacomo Strapazzon, Luca De Toni, Lisa Perilli, Antonella Di Mambro, Barbara Muciaccia, Leonardo Sartori, Riccardo Selice.   

Abstract

WORKING HYPOTHESIS: Mutations in the CYP2R1 gene, highly expressed in the testis and encoding vitamin D 25-hydroxylase, result in a vitamin D deficiency and a defective calcium homeostasis leading to rickets.
OBJECTIVE: Our aim was to investigate CYP2R1 expression in pathological testis samples and relate this to vitamin D metabolism in testiculopathic patients. DESIGN, PATIENTS,
SETTING: Testis samples for in vitro study and 98 young men were transversally evaluated at Padova's Center for Male Gamete Cryopreservation.
METHODS: CYP2R1 mRNA expression and protein production were evaluated by quantitative RT-PCR, Western blot analysis, and immunofluorescence. Hormonal and bone-marker levels, and bone densitometry by dual-energy x-ray absorptiometry, were determined in patients with Sertoli-cell-only syndrome and severe hypospermatogenesis.
RESULTS: We found a lower gene and protein expression of CYP2R1 in samples with hypospermatogenesis and Sertoli-cell-only syndrome (P < 0.05) and a colocalization with INSL-3, a Leydig cell marker, at immunofluorescence. In all testiculopathic patients 25-hydroxyvitamin D levels were significantly lower and PTH levels higher compared to controls (P < 0.05). Furthermore, testiculopathic patients showed osteopenia and osteoporosis despite normal testosterone levels compared with controls both with increased bone-marker levels and altered dual-energy x-ray absorptiometry in the femoral neck and lumbar spine (for all parameters, P < 0.05).
CONCLUSIONS: Our data show an association between testiculopathy and alteration of the bone status, despite unvaried androgen and estrogen levels and no other evident cause of vitamin D reduction. Further studies in larger cohorts are needed to confirm our results.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270327     DOI: 10.1210/jc.2010-1628

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

Review 1.  Effects of hypogonadism on bone metabolism in female adolescents and young adults.

Authors:  Madhusmita Misra
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

Review 2.  The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Authors:  Luisella Cianferotti; Claudio Cricelli; John A Kanis; Ranuccio Nuti; Jean-Y Reginster; Johann D Ringe; Rene Rizzoli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

3.  Estrogens, the be-all and end-all of male hypogonadal bone loss?

Authors:  M R Laurent; E Gielen; D Vanderschueren
Journal:  Osteoporos Int       Date:  2014-11-07       Impact factor: 4.507

Review 4.  The role of vitamin D in male fertility: A focus on the testis.

Authors:  Cristina de Angelis; Mariano Galdiero; Claudia Pivonello; Francesco Garifalos; Davide Menafra; Federica Cariati; Ciro Salzano; Giacomo Galdiero; Mariangela Piscopo; Alfonso Vece; Annamaria Colao; Rosario Pivonello
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

5.  CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo.

Authors:  Jinge G Zhu; Justin T Ochalek; Martin Kaufmann; Glenville Jones; Hector F Deluca
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

Review 6.  Vitamin D and male reproduction.

Authors:  Martin Blomberg Jensen
Journal:  Nat Rev Endocrinol       Date:  2014-01-14       Impact factor: 43.330

7.  Calcium-sensing receptor polymorphisms increase the risk of osteoporosis in ageing males.

Authors:  Andrea Di Nisio; Maria Santa Rocca; Marco Ghezzi; Maurizio De Rocco Ponce; Stefano Taglianetti; Mario Plebani; Alberto Ferlin; Carlo Foresta
Journal:  Endocrine       Date:  2017-10-10       Impact factor: 3.633

8.  Relationship of Vitamin D status with testosterone levels: a systematic review and meta-analysis.

Authors:  S D'Andrea; A Martorella; F Coccia; C Castellini; E Minaldi; M Totaro; A Parisi; F Francavilla; S Francavilla; A Barbonetti
Journal:  Endocrine       Date:  2020-09-03       Impact factor: 3.633

Review 9.  Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons.

Authors:  Marcello Maggio; Fulvio Lauretani; Francesca De Vita; Shehzad Basaria; Giuseppe Lippi; Valeria Butto; Michele Luci; Chiara Cattabiani; Graziano Ceresini; Ignazio Verzicco; Luigi Ferrucci; Gian Paolo Ceda
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

10.  Altered bone status in unilateral testicular cancer survivors: Role of CYP2R1 and its luteinizing hormone-dependency.

Authors:  C Foresta; R Selice; L De Toni; A Di Mambro; U Carraro; M Plebani; A Garolla
Journal:  J Endocrinol Invest       Date:  2012-10-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.